OverviewCook MyoSite Incorporated is developing and commercializing technology related to the collection, selection and expansion of human skeletal muscle cells. Separate research and clinical programs have been established to assist the research community in performing muscle-related research and to develop cellular products for the treatment of a variety of muscle-related disorders.
Cook MyoSite is part of Cook Medical, the first company to introduce minimally invasive interventional devices in the United States. Today, Cook Medical participates in all global markets, integrating device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes. In 2002, Cook Medical formed Cook MyoSite to guide the company into the expanding world of cellular technologies.